Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)

Episode 17 January 12, 2022 00:39:58
Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)
Few & Far Between: Conversations from the Front Lines of Drug Development
Episode 17: Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA)

Jan 12 2022 | 00:39:58

/

Show Notes

Why are advocacy and accessibility so important to rare diseases such as Batten Disease? On this week’s Few & Far Between podcast episode, Biorasi’s Becky Knockemus talks with Amy Fenton Parker, President and CEO at Batten Disease Support and Research Organization (BDSRA).

Other Episodes

Episode 44

October 23, 2024 00:44:29
Episode Cover

Episode 44: Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics

"We don't endeavor to make elite athletes better. We endeavor to make society healthier." - Jonathan Scheiman, PhD, Co-Founder and CEO at FitBiomics Welcome...

Listen

Episode 48

February 18, 2025 00:38:46
Episode Cover

Episode 48: John Celebi, President and CEO, Sensei Bio

"You have to have the right people, the right team, and good science." - John Celebi, President and CEO, Sensei Bio Welcome back to...

Listen

Episode 28

February 23, 2023 00:30:48
Episode Cover

Episode 28: Dr. Alok Tayi, Founder and CEO of VibeBio

“I think one of the key insights and observations you make when you have a child who's sick and you spend time with other...

Listen